/Companies

Amplitude Vascular Systems

Ann Arbor, US · Founded 2019 · 3 known investors

Find your way into Amplitude Vascular Systems

Sign up to see every warm intro you have to Amplitude Vascular Systems

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Amplitude Vascular Systems team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.

Founders & leadership

Amplitude Vascular Systems was founded in 2019 by Robert Chisena, Ph.D..

RC
Robert Chisena, Ph.D.Co-Founder & Chief Technology Officer
ACAndrew Casey
Andrew CaseyExecutiveChief Financial Officer at Amplitude
SGSean Gilligan
Sean GilliganChief Operations OfficerSean Gilligan is an executive in the medical device industry with experience managing FDA-regulated product launches and lifecycle management for Class III and 510(k) devices. He has held leadership roles overseeing cardiology product franchises including interventional stents, coronary therapies, and structural heart valves.
MTMark Toland
Mark TolandExecutiveManaging Director at BioStar Capital
HG
Hitinder Gurm, M.D.Chief Clinical Officer
RC
Robert ChisenaNamed on SEC filing
DL
David LongNamed on SEC filing

Board

LCLouis Cannon
Louis CannonBoard directorFounder, Senior Managing Director at BioStar Capital
HG
Hitinder GurmBoard director
JR
Jason RichardsonBoard director
WH
William H. KuchemanBoard directorManaging Director at BioStar Capital

Investors · 3

Funding

SEC filings, press & company announcements

$29.3M disclosed across 3 of 5 rounds · 2020–2025

▶$23.6MraisedOct 2024 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hitinder GurmDirector
  • Robert ChisenaExecutive Officer
  • Jason RichardsonDirector
  • Louis CannonDirector
  • Andrew CaseyExecutive Officer
  • Sean GilliganExecutive Officer
  • William H. KuchemanDirector
  • Mark TolandExecutive Officer, Director
Offering amount
$36M
Amount sold
$23.6M
Minimum investment
$10K
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedOct 2022 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark TolandExecutive Officer, Director
  • Louis CannonDirector
  • David LongDirector
  • Hitinder GurmDirector
  • Hank KuchemanDirector
  • Robert ChisenaExecutive Officer
Offering amount
$22.4M
Amount sold
$4.4M
Minimum investment
$10K
First sale
Oct 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJul 2020 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LongDirector
  • Mark TolandExecutive Officer, Director
  • Hitinder GurmExecutive Officer, Director
  • Robert ChisenaExecutive Officer, Director
  • Louis CannonDirector
Offering amount
$1.5M
Amount sold
$1.2M
Minimum investment
$10K
Proceeds to insiders
$470K
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does Amplitude Vascular Systems do?
AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.
Who founded Amplitude Vascular Systems?
Amplitude Vascular Systems was founded by Robert Chisena, Ph.D. in 2019.
Who are Amplitude Vascular Systems's investors?
Amplitude Vascular Systems's investors include BioStar Capital, Corewell Health Ventures, ID Ventures.
How much funding has Amplitude Vascular Systems raised?
Amplitude Vascular Systems has disclosed $29.3M raised across 3 of its 5 known rounds.
Where is Amplitude Vascular Systems headquartered?
Amplitude Vascular Systems is headquartered in Ann Arbor, US.